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Abstract: Introduction. Surgery-induced oxidative stress increases the risk of perioperative
complications and delay in postoperative recovery. In mice, short-term preoperative dietary and
protein restriction protect against oxidative stress. We investigated the feasibility of a calorie- and
protein-restricted diet in two patient populations. Methods. In this pilot study, 30 live kidney donors
and 38 morbidly obese patients awaiting surgery were randomized into three groups: a restricted
diet group, who received a synthetic liquid diet with 30% fewer calories and 80% less protein for five
consecutive days; a group who received a synthetic diet containing the daily energy requirements
(DER); and a control group. Feasibility was assessed using self-reported discomfort, body weight
changes, and metabolic parameters in blood samples. Results. Twenty patients (71%) complied
with the restricted and 13 (65%) with the DER-diet. In total, 68% of the patients reported minor
discomfort that resolved after normal eating resumed. The mean weight loss on the restricted diet was
significantly greater (2.4 kg) than in the control group (0 kg, p = 0.002), but not in the DER-diet (1.5 kg).
The restricted diet significantly reduced levels of serum urea and plasma prealbumin (PAB) and
retinol binding protein (RBP). Conclusions. A short-term preoperative calorie- and protein-restricted
diet is feasible in kidney donors and morbidly obese patients. Compliance is high and can be
objectively measured via changes in urea, PAB, and RBP levels. These results demonstrate that this
diet can be used to study the effects of dietary restriction on surgery-induced oxidative stress in a
clinical setting.
Keywords: dietary restriction; protein restriction; compliance; feasibility; preoperative diet
1. Introduction
Reactive oxygen species (ROS) that the body produces during surgical procedures induce
oxidative stress and lead to imbalances in homeostasis [1,2]. The subsequent stress response elicits
hormonal, metabolic, and immunological changes that increase the risk of perioperative complications
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and may hamper postoperative recovery [1,3]. This risk is increased by preexisting factors such
as obesity [4], and by perioperative factors such as ischemia-reperfusion injury (IRI) during organ
transplantation [5,6]. Although treatments that decrease ROS production could reduce perioperative
and postoperative complications, no effective clinical therapy is currently available.
In animal studies, dietary restriction (DR) protects against ROS-induced damage. We
demonstrated previously that short-term preoperative 30% DR protects against the oxidative damage
induced by renal IRI in mice and improves postoperative survival and kidney function [7–9],
and similarly protects against liver IRI [10]. The beneficial effects of fasting on renal IRI are also
observed in aged obese mice of both sexes, suggesting that DR induces protection against ROS
independent of age and sex [11].
Translating DR to humans in a clinical setting is difficult, because of the effort required by patients
to voluntarily restrict their calorie intake. In addition, DR goes against the generally held beliefs
that patients should be well fed before surgery to prevent malnutrition. Finally, the diet composition
and duration that induces similar benefits in humans as observed in rodents is not known [12].
Studies of the effects of a very low-calorie diet prior to bariatric surgery report contradictory effects
on perioperative and postoperative outcomes, and adherence to the diet in these studies was not
measured objectively [13,14]. In our previous pilot study in live kidney donors, we showed that three
days of 30% DR followed by 24 h of fasting prior to kidney donation was feasible and safe, but had
limited effects on outcome [15,16]. Subsequent results from murine experiments suggested that the
beneficial effects were due mainly to restriction in protein intake [17]. The effect of protein restriction
(PR) has not yet been investigated in a clinical setting.
Therefore, our current pilot study investigated the feasibility of a preoperative diet combining DR
and PR in two patient populations: live kidney donors and morbidly obese patients scheduled
for laparoscopic donor nephrectomy or laparoscopic bariatric surgery, respectively. To identify
objective markers of diet adherence, we measured both standard and experimental metabolic markers.
Our results showed that short-term DR is feasible and represents a promising next step in investigating
the effects of preoperative DR on surgery-related outcome in a clinical setting.
2. Subjects and Methods
2.1. Study Design
This pilot study was designed as a prospective multicenter pilot study. The study was approved
by the Medical Ethics Committee (METC, MEC number 2012-134) of the Erasmus University Medical
Center, Rotterdam, The Netherlands, and by the Board of Directors of the Maasstad Hospital,
Rotterdam, The Netherlands. The study procedures were in accordance with the METC guidelines.
The trial is registered as the PROTECT trial in the Dutch trial registry database using trial code
3663 (www.trialregister.nl). This manuscript was prepared in accordance with the CONSORT 2010
statement [18], according to the Declaration of Helsinki.
2.2. Inclusion and Exclusion Criteria
The coordinating investigator approached patients at the hospitals’ outpatient clinic during their
scheduled doctor appointments. All patients included in the study gave written informed consent to
participate. Patients were informed that this study only aimed to establish the feasibility of the diet in
surgical patients. A patient flowchart showing inclusions/exclusions and randomization procedures
is depicted in Figure S1.
2.2.1. Kidney Donors
Kidney donors visited the outpatient clinic at the Erasmus MC, University Medical Center
Rotterdam between February 2013 and May 2014. To be eligible for the study, patients had to be
between 18 and 70 years old, have a BMI ě 19, could not participate in another clinical trial in the
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30 days prior to the day they were approached, and could have no known allergies to any of the
ingredients in the diets. An additional exclusion criterion was a surgery performed outside the Erasmus
MC due to participation in the cross-over kidney donation program [19]. Out of 124 kidney donors,
90 were eligible to participate in the study and were approached. Initially, 45 donors gave informed
consent. After the outpatient clinic visit and before the scheduled surgery, 15 donors withdrew from
the study for personal or logistical reasons (Figure S1). Included dropouts after randomization were
replaced until the desired number of inclusions was reached. Thirty donors were equally (n = 10)
randomized into each of the three intervention groups.
2.2.2. Bariatric Surgery Patients
The morbidly obese patients visited the outpatient clinic at the Maasstad Hospital between
March 2013 and August 2014. To participate in the study, patients had to be between 18 and 60 years
of age with a BMI ě 40, could not have participated in another clinical study in the 30 days prior
to the day they were approached, and could have no known allergies to any of the ingredients in
the diets. Additional exclusion criteria were the presence of diabetes mellitus or morbid obesity
caused by a known genetic syndrome or genetic defect. Diabetic patients were excluded to eliminate
this confounding variable between the two surgery groups, as diabetic patients are not admitted
to the live kidney donor program. Diabetes mellitus was defined as a fasted plasma glucose level
ě7 mmol/L as measured on two different days, or as either a fasted plasma glucose level ě7 mmol/L
or a non-fasted plasma glucose level ě11.1 mmol/L with symptoms of hyperglycemia (such as thirst
and polyuria). Out of 143 morbidly obese patients, 84 were eligible to participate and were therefore
approached; 54 provided written informed consent. Sixteen patients dropped out of the study for
various reasons (Figure S1). Included dropouts after randomization were replaced until the desired
number of inclusions was reached. Since a high number of dropouts after randomization and start of
the restricted occurred due to logistical reasons, additional patients were included in the restricted diet
group. Eventually, 18 patients were randomized to the restricted diet, 10 patients to the DER-diet and
10 patients to the control group.
2.3. Dietary Intervention
All dietary interventions lasted for 5 consecutive days and were given in an outpatient setting.
For the kidney donors, the diet was initiated 6 days prior to surgery. For the morbidly obese patients,
the diet started between several weeks to 5 days prior to the surgery date. After providing written
informed consent, patients were randomized into one of three groups. During the study, patients
were offered a contact person whom they were able to approach with an accessibility of 24 h per day
with questions regarding the diet, which they frequently did. Directly after completion of the diet,
patients visited the outpatient clinic to evaluate their experience, and to donate a venous blood
sample. The first group received a 30% DR and 80% PR restricted diet. This synthetic liquid diet
containing an estimated 70% of the individual’s required calories and 20% of the individual’s protein,
based on the basal metabolic rates and on the daily energy requirements (DER) as calculated with
the Harris–Benedict formula [20]. The Harris–Benedict formula takes into account sex, height, age,
body weight and estimated activity level. This formula is validated up to a BMI of 40. Whenever
an individual had a BMI > 40, the body weight corresponding to a BMI of 40 was used to calculate
the DER. Normal protein intake was set at 15% of the total calories based on the DER. Participants
received calorie- and protein-restricted powder shakes (Scandishake® Mix, Nutricia Advanced Medical
Nutrition, The Netherlands) as the main component of the diet. The shake was provided as a powder
consisting of 4% protein, 53% carbohydrates and 43% fat, and was diluted with water. The main
protein source was casein with a limited amount of whey protein (Table S1). The shakes were combined
with a limited amount of protein-restricted products (mainly fruits and vegetables) until the desired
individual diet was reached. These protein-restricted products included: all fruits except bananas,
all vegetables in a limited amount of 200 g per day with the exception of asparagus, and a maximum
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of one piece of gingerbread per day. The second group received a synthetic diet that was isocaloric to
each individual’s DER (termed the DER-diet), which was also calculated using the Harris–Benedict
formula [20]. The DER-diet was offered as a shake (Nutridrink® Compact, Nutricia Advanced Medical
Nutrition, The Netherlands) and was consumed without further dilution. This shake consisted of 16%
protein, 49% carbohydrates and 35% fat (Table S1). A limited amount of protein-restricted products as
offered to the restricted diet group, was added until the individual’s DER was reached and average
protein intake was an estimated 15% of all calories. All participants, randomized to either the restricted
diet or the DER-diet, were blinded to which diet they received. The third group did not receive a
synthetic diet or a dietary intervention. This group continued their usual daily eating pattern. Patients
were asked to keep a diet diary during the period in which patients in the other two groups received
the synthetic diet. Using this diary, their daily nutritional intake was measured and calculated for
5 days, resulting in mean overall daily nutritional intake values. Experienced dieticians analyzed the
diet diaries and calculated the DER, the average kilocalorie intake, and the average protein, fat and
carbohydrate intake.
2.4. Outcome Parameters
2.4.1. Subjective Measurements
To analyze subjective health outcomes, all patients were asked to fill in a standardized
questionnaire, the Visual Analogue Score (VAS) for evaluation of nausea, pain and general
wellbeing [21]. The VAS questionnaire uses a scale ranging from 0 to 10, with 0 representing no
pain, nausea or decrease in wellbeing and 10 corresponding to the worst pain, nausea or decrease in
wellbeing. The questionnaires were completed at three different time points: 1 day prior to starting
the dietary intervention, on day 3 of the intervention and one day after completion of the 5-day
intervention period when normal food intake was resumed. Side effects and discomfort were defined
as any secondary effect related to the intervention. A distinction was made between major side effects
and minor discomfort. Major side effects were defined as symptoms related to the intervention that
remained days or weeks after the intervention or that required hospitalization. Minor discomfort
included symptoms that caused discomfort during the intervention, but immediately disappeared
after the dietary intervention.
2.4.2. Objective Measurements
Before and after the dietary intervention, the following data were obtained from all patients: body
weight, age, sex, length, and estimated physical activity level and duration. During the outpatient
clinic visit and 1 day after the dietary intervention, two tubes of blood were collected: a 5.0 mL BD
Vacutainer CPT tube (Franklin Lakes, NJ, USA) and a 5.0 mL BD Vacutainer® SST™ II Advance serum
tube. After centrifuging for 20 min at 1500ˆ g or for 10 min at 2300ˆ g, respectively, both the plasma
and serum were collected and stored at´80 ˝C until further analysis. Only blood samples from patients
that had fasted overnight were used for the analysis. “Fasted” was defined as no food intake overnight,
i.e., for at least 8 h prior to blood withdrawal. In serum samples the metabolic parameters albumin,
urea, creatinine, glucose, ferritin, cholesterol, free fatty acids, triglycerides and high-density lipoprotein
(HDL), and in plasma samples parameters prealbumin (PAB) and retinol binding protein (RBP) were
measured and processed on the UniCel DˆC 800 Synchron (R) Chemistry System (Beckman, Poway,
CA, USA). Insulin was analyzed using the Access 2 ImmunoAssay System (Beckman) (Table S2).
In addition, 143 metabolic markers were measured in serum samples by Brainshake (Brainshake
Ltd., Helsinki, Finland), as summed up in a list of the service deliverables provided by Brainshake
(http://www.brainshake.fi/service-deliverables-web-v1_0) [22]. A schematic overview of all of the
parameters and measurements, as well as the experimental timeline, is shown in Figure S2.
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2.5. Randomization
Randomization was performed using computer-generated lists, which were printed out and put
into opaque envelopes by an employee not involved in the study. The first 30 sequential numbers
of each group (i.e., kidney donors and morbidly obese patients) where generated at once. Sequential
numbers for the two groups were distinguishable. After these blocks, the total number of dropouts was
randomized in one block by the same procedure. The coordinating investigator approached patients
eligible for the study at the hospitals’ outpatient clinic during their scheduled doctor appointments.
Allocation occurred after informed consent was given. All participants randomized to either the
restricted diet or the DER-diet were blinded to which diet they received.
2.6. Statistical Analysis
Categorical data are presented as numbers (percentage) and continuous variables as mean
(SD/normal distribution) or median (interquartile distance/no normal distribution). The data were
tested for normality using the Shapiro–Wilks test and visual assessment. Continuous data were
compared using either the non-parametric Mann-Whitney test or the t-test for parametric data. Related
samples were analyzed using the non-parametric Wilcoxon signed rank test. Semi-quantitative scoring
of the questionnaires was performed via the paired t-test. Significance was set at p < 0.05. A Bonferroni
correction for multiple testing was performed on the metabolic parameters. A p-value of ď 0.002 was
considered significant. The analyses were performed using Statistical Packages for Social Sciences
21.0 (SPSS Inc., Chicago, IL, USA), GraphPad Prism (GraphPad Software Inc., La Jolla, CA, USA,
version 5.01), and Office Excel (2010). This study was designed as a pilot study and therefore no power
calculations were performed.
3. Results
3.1. Study Population
Of the 45 live kidney donors that were included initially and who underwent randomization, 30
were equally distributed (n = 10) in the three groups and completed the study. Of the 54 morbidly
obese patients that were included initially, 38 were distributed in the three groups with 18 patients in
the restricted diet group, 10 in the DER-diet group, and 10 in the control group (Figure S3). At baseline,
the morbidly obese patients group had significantly higher average body weight and BMI and was
significantly more often female (Table 1). There were no differences in the baseline characteristics after
randomization between dropouts and patients who completed the study.
Table 1. Baseline characteristics of the study population.
Parameter Live Kidney Donors (n = 30) Morbidly Obese Patients (n = 38) p-Value
Age, years 47 ˘ 13 43 ˘ 9 0.17
Sex, F/M 12/18 31/7 0.003
Body weight, kg 82.8 ˘ 17.3 129.1 ˘ 24.6 <0.001
BMI, kg/m2 26.6 ˘ 4.6 44.5 ˘ 5.4 <0.001
Baseline characteristics of the study population; Values are depicted as mean ˘ standard deviation; Significant
p-values are depicted in bold; At baseline, the morbidly obese patients group had a significantly higher average
body weight and BMI and were significantly more often female.
3.2. Compliance with the Diets by Kidney Donors and Morbidly Obese Patients
A total of 10 live kidney donors and 18 morbidly obese patients were randomized into the
restricted diet group. This group received a synthetic diet with a mean calorie restriction of 30% and
a mean protein restriction of 80% relative to each patient’s DER. Twenty individuals (71%) reported
completing the five-day diet (Figure S2). Eight out of 10 kidney donors (80%), and 12 out of 18 morbidly
obese patients (67%) reported completing the restricted diet.
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Ten donors and ten morbidly obese patients were randomized into the DER-diet. This group
received a synthetic diet which resulted in a mean DR of 4% without PR. Thirteen out of 20 (65%)
individuals receiving this diet reported completing the diet. Of the kidney donors, four out of 10 (40%)
completed the diet; nine out of 10 (90%) morbidly obese patients completed the diet (Figure S2).
Twenty patients were randomized into the control group. Nine out of 10 donors (90%) filled in
the diary for five consecutive days, while seven out of 10 (70%) morbidly obese patients filled in the
diary. An analysis of the dietary diaries was performed to calculate average percentages of protein,
carbohydrate and fat-intake. Nine patients in the control group had complete filled-in diaries and
were included in the analysis. Average nutrient content consisted of 18% protein, 48% carbohydrates
and 34% fat.
3.3. Discomfort during the Dietary Interventions
No major side effects were reported during or after the dietary interventions.
Twenty out of 28 individuals (71%) receiving the restricted diet reported 35 instances of
minor discomfort that resolved during or directly after finishing the diet (Figure 1). In general,
the Scandishake drinks were well tolerated and were reported to be palatable. A higher percentage of
kidney donors (40%) than morbidly obese patients (20%) reported discomfort related to nutritional
intake, e.g., hunger and appetite. In contrast, a higher percentage of morbidly obese patients (90%)
than kidney donors (20%) reported gastrointestinal discomfort, e.g., stool change, nausea, stomachache
and dyspepsia. Three out of eight patients whom did not complete the diet mentioned gastrointestinal
discomfort as the main reason.
Of patients on the DER-diet, 13 out of 20 (65%) reported 26 instances of minor discomfort during
the diet. Kidney donors reported mostly gastrointestinal discomfort (90%), while the morbidly obese
reported gastrointestinal discomfort (50%) and discomfort related to nutritional intake, such as distaste
and appetite (50%).
Discomfort was scored semi-quantitatively using the VAS questionnaires at time points before,
during, and after the diet. Patients that completed the restricted diet had significantly higher levels of
nausea (p = 0.009) and decreased wellbeing (p = 0.02) during the diet than before the diet (Figure 2).
These scores returned to baseline on day 1 after finishing the diet. There were no differences in pain
scores at the three time points. Those on the DER-diet also reported higher nausea scores during the
intervention (p = 0.04). No differences were seen for the pain scores before, during, and after the diet
for either dietary intervention, no changes were reported in the control group.
3.4. Body Weight
Individuals who adhered to the restricted diet lost on average 2.5% of their total body weight,
corresponding to 2.4 ˘ 1.4 kg, based on the body weight measurements at the outpatient clinic before
the start of the dietary restriction and on the day after its completion (Figure 3). This body weight loss
was significantly greater (p = 0.002) than in individuals without dietary restriction (n = 6), who did not
lose weight (0.2% of their total body weight). The body weight changes were not significantly different
between the kidney donors and bariatric surgery patients. The DER-diet (n = 3) resulted in an average
loss of 1.5 ˘ 1.4 kg (1.7%), which was not significantly different from either the restricted diet group or
the control group.
3.5. Markers of Metabolism and Compliance
Before and after all dietary interventions, blood samples were collected and serum and plasma
was stored for further analyses. Only samples taken from fasted patients were used for these analyses.
Due to the exclusion of samples from patients who did not fast, too few samples were available from
the kidney donors for statistical analysis within this group. Therefore, the data from both kidney
donors and morbidly obese patients were pooled. Due to a variation in baseline levels between the
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different patient groups, relative differences were compared between groups using the change in
values before and after the intervention.
Nutrients 2016, 8, 306  7 of 16 
 
Figure 1. The number of side effects as percentages of participants in groups consuming a restricted 
diet and a daily energy requirements diet (DER‐diet). (A) Side effects of the dietary restriction and 
protein  restriction diet  in  the kidney donors were mostly  related  to nutritional  intake and  to  the 
gastrointestinal  tract;  (B) Morbidly obese patients  showed  relatively more gastrointestinal discomfort; 
(C) A total of 90% of the kidney donors reported gastrointestinal discomfort during the DER‐diet; (D) 
This percentage was lower in the morbidly obese patients and was the same as discomfort related to 
nutritional  intake. Effects are clustered based on  the origin of  the symptoms. Within each cluster, 
each side effect is depicted in a different shade of color.   
   
Stool change Nausea Stomach ache Dyspepsia Breath Appetite
Hunger Distaste Weary Headache Muscle ache No complaints
0
20
40
60
80
100
Gastro‐
intestinal
Nutritional
intake
Well‐
being
Neuro‐
logic
None
reported
Pa
rt
ic
ip
an
ts
 (%
)
(A)       Restrictied Diet ‐ Live Kidney Donors
0
20
40
60
80
100
Gastro‐
intestinal
Nutritional
intake
Well‐
being
Neuro‐
logic
None
reported
Pa
rt
ic
ip
an
ts
 (%
)
(B)       Restrictied Diet ‐ Morbid Obese Patients
0
20
40
60
80
100
Gastro‐
intestinal
Nutritional
intake
Well‐
being
Neuro‐
logic
None
reported
Pa
rt
ic
ip
an
ts
 (%
)
(C)       DER‐diet  ‐ Live Kidney Donors
0
20
40
60
80
100
Gastro‐
intestinal
Nutritional
intake
Well‐
being
Neuro‐
logic
None
reported
Pa
rt
ic
ip
an
ts
 (%
)
(D)       DER‐diet  ‐ Morbid Obese Patients
Figure 1. The number of side effects as percentages of participants in groups consuming a restricted
diet and a daily energy requirements diet (DER-diet). (A) Side effects of the dietary restriction and
protein restriction diet in the kidney donors were mostly related to nutritional intake and to the
gastrointestinal tract; (B) Morbidly obese patients showed relatively more gastrointestinal discomfort;
(C) A total of 90% of the kidney donors reported gastrointestinal discomfort during the DER-diet;
(D) This percentage was lower in the morbidly obese patients and was the same as discomfort related
to nutritional intake. Effects are clustered based on the origin of the symptoms. Within each cluster,
each side effect is depicted in a different shade of color.
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extensively assessed via a panel of 147 metabolic parameters (Table S2). The impact of the two diets 
on  protein metabolism was measured  using  serum  albumin,  urea  and  amino  acids  levels.  The 
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Figure 2. Visual Analogue Scores (VAS) for nausea, pain, and wellbeing before, during, and after each
dietary intervention. (A) The nausea scores increased significantly for patients on the restricted diet
and the DER-diet but normalized to baseline levels directly after the intervention period was over;
(B) The pain scores did not change significantly during the dietary interventions; (C) The restricted
diet resulted in significant decreased VAS wellbeing scores during the diet compared to before, but
normalized again directly after the intervention period was over; * p < 0.05. Bars represent the standard
error of the mean; DER = daily energy requirements.
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i re 3. weight changes in the three dietary intervention groups. Patients on the restricted diet
lost an aver g of 2.5% of their body weight, corresponding to 2.4 ˘ 1.4 kg; This body weight loss was
significantly greater than in the contr l g up, which showed no change; The DER-diet resulted in a
1.7% loss in body weight (1.5˘ .4 kg), which was not significantly different than the two other gr ups;
Changes are shown a percentag s ompared to the body w ight at baseline; ** p < 0.01. Bars represent
the standard error of th mean. DER = daily energy requirements.
eta lic c a es e t t e ietar i ter e ti s as ell as i tra r ariati s ere
exte si el assesse via a panel of 147 metabolic parameters (Table S2). The impact of the two diets on
protein metabolism was measured sing serum albu in, rea and amino acids levels. The restricted
diet did not significantly cha ge serum albumin (Figure 4A). Serum albumin was increased by 7% after
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the DER-diet, but did not reach significance (p = 0.006). The increase after the DER-diet showed a trend
towards higher levels compared to the relative change in the restricted diet (p = 0.006) and the control
group (p = 0.003) (Table 2). No significant changes were seen in the control group. Serum urea was on
average 37.5% lower after the restricted diet than before the diet (p = 0.002), which was also significantly
different from the DER-diet (p < 0.001) and the control group (p < 0.001) (Figure 4B). There were no
significant changes in serum urea in the DER-diet group or in the control group. Of the serum amino
acids measured, none differed significantly between the groups (Figure 4C,D). The relative decrease of
18% in valine levels was significant compared to the relative difference of the DER-diet and the control
group (Table 2). The cumulative sum of BCAAs, namely isoleucine, leucine and valine, showed a trend
towards a decrease after the restricted diet (p = 0.005), but not after the DER-diet or in the control
group. The relative decrease of 16% in the combined BCAAs also showed a trend compared to the
relative change after the DER-diet (p = 0.004) and the control group (p = 0.004). Other amino acid levels
were not significantly changed after any of the diets.
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Figure 4. Serum levels of albumin, urea, valine and leucine after the three dietary interventions. (A) 
Serum albumin did not  significantly  change  in any of  the groups;  (B)  serum urea was decreased 
significantly after  the  restricted diet, while  it did not  change after  the DER diet or  in  the  control 
group; both serum valine (C) and leucine (D) did not differ between groups, but did show a trend 
towards a decrease after the restricted diet; red symbols = kidney donors, as opposed to morbidly 
obese individuals (black or gray symbols); DER = daily energy requirements. 
   
Figure 4. Serum levels of albumin, urea, valine and leucine after the three dietary interventions.
(A) Serum albumin did not significantly change in any of the groups; (B) serum urea was decreased
significantly after the restricted diet, while it did not change after the DER diet or in the control
group; both serum valine (C) and leucine (D) did not differ between groups, but did show a trend
towards a decrease after the restricted diet; red symbols = kidney donors, as opposed to morbidly
obese individuals (black or gray symbols); DER = daily energy requirements.
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Table 2. Relative changes in metabolic parameters, amino acids and compliance markers after the
dietary interventions with their corresponding p-value of intragroup differences.
Parameter
Intervention
Restricted Diet
(% Change)
DER-Diet
(% Change)
Control
(% Change)
p-Value
Restricted-
DER
p-Value
Restricted-
Control
p-Value
DER- Control
Metabolic
Albumin (g/L) ´9 +7.2 ´1.9 0.006 0.212 0.003
Urea (mmol/L) ´37.5 +13.8 ´2.6 <0.0001 <0.0001 0.067
Creatinine
(mmol/L) +15.1 12.2 ´2.0 0.51 0.009 0.03
Glucose (mmol/L) ´1.8 ´0.6 +6.2 0.76 0.10 0.20
Ferritin +17.5 +21.2 +20.2 0.73 0.89 0.95
Insulin (pmol/L) +27.2 +13.7 +52.2 0.70 0.68 0.34
Amino Acids
Alanine (mmol/L) ´3.6 +3.1 ´5.8 0.37 0.74 0.20
Glutamine
(mmol/L) +2.1 +0.1 +2.9 0.72 0.90 0.51
Glycine (mmol/L) +7.8 +3.3 +5.0 0.37 0.61 0.73
Histidine (mmol/L) ´11.0 ´8.6 ´0.2 0.72 0.15 0.12
Isoleucine
(mmol/L) ´12.8 ´2.7 +11.0 0.15 0.03 0.15
Leucine (mmol/L) ´11.1 +2.1 +8.0 0.01 0.01 0.37
Phenylalanine
(mmol/L) ´4.9 +5.3 +6.4 0.06 0.03 0.81
Tyrosine (mmol/L) ´10.0 +5.0 0.6 0.09 0.19 0.56
Valine (mmol/L) ´17.9 +0.7 +11.6 0.002 0.003 0.22
BCAA * (mmol/L) ´16.4 ´1.3% +8.8% 0.004 0.004 0.22
Miscellaneous
Prealbumin (mg/L) ´17.2 +1.0 ´1.2 0.002 0.0001 0.77
Retinol Binding
Protein (mg/L) ´20.5 +5.6 ´0.9 0.0002 0.0001 0.26
Relative changes in metabolic parameters, amino acids and compliance markers after the dietary interventions
with their corresponding p-value of intragroup differences. Values are depicted as mean ˘ standard error of
the mean. Significant p-values are depicted in Italics. Significant p-values after the Bonferroni correction for
multiple testing are depicted in bold and Italics. * BCAA = branched chain amino acids; cumulative sum of
isoleucine, leucine and valine.
Neither serum markers glucose nor insulin changed significantly before versus after the
intervention in three diet groups (Table 3). After the restricted diet, high-density-lipoprotein (HDL)
was significantly decreased (p = 0.006), but did not remain significant after the Bonferroni correction
for multiple testing. Detailed analysis of HDL-subclasses showed a trend towards a decrease in the
medium HDL-particles, while other HDL-subclasses were not affected (data not shown). The DER-diet
group had higher free fatty acids after the intervention (p = 0.01), based on an increase of saturated
fatty acids (SFA) (p = 0.002). Furthermore, the DER-diet resulted in a significant decrease in serum
cholesterol (p = 0.03) Lipoprotein subclasses very small very-low-density-lipoprotein (XS-VLDL),
intermediate-density-lipoprotein (IDL) and large low-density-lipoprotein (L-LDL) showed a trend
towards a decrease due to the DER-diet, but this did not reach significance (data not shown).
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Table 3. Changes in metabolic parameters after the dietary intervention groups.
Parameter
Intervention Restricted Diet DER-Diet Control
Before After p-Value Before After p-Value Before After p-Value
Metabolic
Albumin (g/L) * 35.2 ˘ 1.2 32.3 ˘ 2.4 0.09 41.3 ˘ 0.8 44.2 ˘ 0.9 0.006 39.9 ˘ 1.0 39.0 ˘ 1.3 0.57
Urea (mmol/L) 4.3 ˘ 0.3 2.6 ˘ 0.2 0.0002 5.5 ˘ 0.3 6.1 ˘ 0.4 0.19 4.7 ˘ 0.4 4.5 ˘ 0.4 0.36
Creatinine (mmol/L) 72.6 ˘ 3.3 83.4 ˘ 4.4 0.002 69.5 ˘ 3.7 78.5 ˘ 5.6 0.01 66.4 ˘ 6.4 63.5 ˘ 5.5 0.92
Glucose (mmol/L) 4.9 ˘ 0.2 4.8 ˘ 0.2 0.53 5.7 ˘ 0.2 5.6 ˘ 0.2 0.85 5.2 ˘ 0.3 5.8 ˘ 0.3 0.13
Insulin (pmol/L) ** 62.4 ˘ 18.6 60.9 ˘ 18.9 1.00 98.4 ˘ 18.1 106.1 ˘ 23.2 0.28 157.6 ˘ 46.3 195.5 ˘ 65.1 0.46
Cholesterol (mmol/L) 5.1 ˘ 0.5 4.5 ˘ 0.6 0.03 4.7 ˘ 0.3 4.5 ˘ 0.3 0.13 4.4 ˘ 0.3 4.8 ˘ 0.3 0.19
Free fatty acids (mmol/L) 0.52 ˘ 0.03 0.72 ˘ 0.09 0.09 0.55 ˘ 0.05 0.67 ˘ 0.04 0.01 0.48 ˘ 0.05 0.56 ˘ 0.09 0.49
Saturated fatty acids (mmol/L) 4.18 ˘ 0.25 4.01 ˘ 0.21 0.11 3.46 ˘ 0.25 3.03 ˘ 0.19 0.002 3.59 ˘ 0.17 3.60 ˘ 0.17 0.27
Triglycerides (mmol/L) 1.31 ˘ 0.19 1.37 ˘ 0.25 0.97 1.60 ˘ 0.42 1.51 ˘ 0.28 0.92 1.57 ˘ 0.27 1.66 ˘ 0.31 0.70
HDL (mmol/L) 1.32 ˘ 0.09 1.12 ˘ 0.12 0.006 1.27 ˘ 0.09 1.24 ˘ 0.10 0.30 1.18 ˘ 0.11 1.28 ˘ 0.11 0.59
LDL (mmol/L) 3.9 ˘ 0.7 4.0 ˘ 0.7 0.69 2.9 ˘ 0.3 2.7 ˘ 0.3 0.06 2.6 ˘ 0.3 2.9 ˘ 0.3 0.32
Amino Acids
Alanine (mmol/L) 0.45 ˘ 0.02 0.43 ˘ 0.4 0.49 0.44 ˘ 0.02 0.45 ˘ 0.02 0.77 0.45 ˘ 0.02 0.42 ˘ 0.02 0.37
Glutamine (mmol/L) 0.47 ˘ 0.02 0.47 ˘ 0.02 0.63 0.49 ˘ 0.02 0.49 ˘ 0.02 1.00 0.45 ˘ 0.02 0.46 ˘ 0.02 0.35
Glycine (mmol/L) 0.26 ˘ 0.007 0.28 ˘ 0.01 0.08 0.28 ˘ 0.009 0.29 ˘ 0.01 0.85 0.25 ˘ 0.006 0.26 ˘ 0.009 0.18
Histidine (mmol/L) 0.06 ˘ 0.003 0.06 ˘ 0.004 0.08 0.07 ˘ 0.003 0.06 ˘ 0.002 0.01 0.07 ˘ 0.003 0.07 ˘ 0.004 0.83
Isoleucine (mmol/L) 0.06 ˘ 0.004 0.05 ˘ 0.002 0.06 0.05 ˘ 0.005 0.05 ˘ 0.003 0.43 0.06 ˘ 0.004 0.06 ˘ 0.005 0.40
Leucine (mmol/L) 0.08 ˘ 0.005 0.07 ˘ 0.003 0.02 0.08 ˘ 0.004 0.08 ˘ 0.003 0.63 0.08 ˘ 0.005 0.09 ˘ 0.006 0.50
Phenylalanine (mmol/L) 0.08 ˘ 0.005 0.08 ˘ 0.003 0.23 0.08 ˘ 0.003 0.09 ˘ 0.003 0.08 0.08 ˘ 0.004 0.09 ˘ 0.005 0.03
Tyrosine (mmol/L) 0.05 ˘ 0.003 0.05 ˘ 0.002 0.08 0.06 ˘ 0.003 0.06 ˘ 0.004 0.70 0.06 ˘ 0.004 0.06 ˘ 0.003 0.58
Valine (mmol/L) 0.16 ˘ 0.007 0.13 ˘ 0.004 0.004 0.19 ˘ 0.01 0.18 ˘ 0.007 1.00 0.18 ˘ 0.01 0.20 ˘ 0.01 0.17
Changes in metabolic parameters after the dietary intervention groups. Values are depicted as mean ˘ standard error of the mean. Significant P-values are depicted Italics, while
significant p-values after the Bonferroni correction for multiple testing are depicted in bold and Italics; * baseline levels in the restricted diet group are significantly lower than in the
DER-diet and control group. This is due to a high percentage of patients with serum albumin levels which lay below the normal values of 35–55 g/L. ** baseline levels in the control
group are higher, due to patients with levels of serum insulin of >180 pmol/L.
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Both plasma PAB (Figure 5A) and plasma RBP (Figure 5B) were significantly lower after the
restricted diet compared to levels before starting the diet, decreasing on average 27% (p = 0.0002) and
22% (p = 0.001), respectively. All except one patient in the restricted diet group showed a decrease in
serum PAB and RBP. The eight patients who did not complete the restricted diet showed an average
increase of 10% in PAB (Figure 5C) and 7% in RBP (Figure 5D), which was significantly different than
the measures of those who completed the diet. No significant changes were seen in the DER-diet and
in the control group in both PAB (Figure 5A) and RBP (Figure 5B).
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Figure 5. Plasma levels of prealbumin (PAB) and retinol binding protein (RBP) after the three dietary 
interventions.  (A)  Prealbumin  (PAB)  and  (B)  retinol  binding  protein  (RBP)  both  decreased 
significantly after the restricted diet, with no changes seen in the DER‐diet group or in the control 
group; (C) PAB and (D) RBP did not change in patients who did not complete the restricted diet. The 
two  corresponding  values  for  the  individual patients  are  connected with  a  line.  *  p  ≤  0.002. Red 
symbols = kidney donors in the restricted diet group. DER = daily energy requirements. 
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Figure 5. Plasma levels of prealbumin (PAB) and retinol binding protein (RBP) after the three dietary
interventions. (A) Prealbumin (PAB) and (B) retinol binding protein (RBP) both decreased significantly
after the restricted diet, with no changes seen in the DER-diet group or in the control group; (C) PAB and
(D) RBP did not change in patients who did not complete the restricted diet. The two corresponding
values for the individual patients are connected with a line. * p ď 0.002. Red symbols = kidney donors
in the restricted diet group. DER = daily energy requirements.
4. Discussion
In this study, we showed that both kidney donors and morbidly obese patients are able to adhere
to a synthetic calorie- and protein-restricted diet for five consecutive days with only minor discomfort.
The metabolic markers PAB and RBP showed the strongest correlation with adherence to the diet, and
together with serum urea could form a potential objective marker set to validate compliance to a diet
comprising 30% DR and 80% PR.
The rationale for combining DR and PR in this clinical diet was based on the known beneficial
effects of short-term DR and short-term PR [17,22,23]. We showed previously that several DR
regimens protect against renal IRI in mice and result in up-regulation of anti-oxidants, reduction
of pro-inflammatory cytokines, improved kidney function, and increased survival [7,24]. DR also
protects against IRI in aged-obese mice of both sexes, suggesting that the DR-induced effects on the
stress response could be broadly applied [11].
It is not clear how the benefits of DR should be translated to humans in a clinical setting.
Longer-term DR (e.g., for weeks) is considered undesirable, since feelings of hunger and fatigue
and the risk of malnutrition could alter the wellbeing of patients prior to surgery. However, a shorter
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period could be insufficient to confer the same beneficial effects as in animal studies. Most clinical
studies of preoperative DR have been performed in bariatric surgery patients and were designed to
evaluate the effects of DR on weight loss and liver size reduction [13,14]. One study showed reduction
in steatosis and steatohepatitis after liver resection due to preoperative dietary and fat restriction [25].
We previously used a DR regimen of three days of 30% DR followed by 24 h of fasting in live kidney
donors, which proved to be feasible; unfortunately, this did not induce a beneficial response similar to
that seen in mice [15,16]. This could be because the DR duration or restriction level was insufficient, or
because the diet did not include PR. Based on this experience [15,16], we extended the number of days
of the diet, and restricted protein intake by 80% in addition to the 30% DR.
A total adherence rate of 71% was reached, which was comparable between kidney donors and
morbidly obese patients. Many factors influence adherence, such as the duration of the intervention
as well as the frequency of daily doses. Osterberg et al. showed that the average adherence rate
in clinical trials ranges between 43% and 78% [26]. They also reported an average adherence rate
between 30% and 80% in patients who took three to four medication doses a day [26], which is
comparable to the to three to four shakes per day in the restricted diet group of our study. In light
of these results, our compliance rate is acceptable considering the fact that these patients did not
receive the diet immediately prior to surgery, and therefore did not expect a beneficial effect. Further
studies investigating the potential beneficial effects of this dietary regimen, might further increase the
compliance rate in these patient populations.
Safety and discomfort of a preoperative diet are important factors to consider in terms of
compliance and applicability. We found that serum albumin, insulin and ferritin measures did not
change as a result of the restricted diet, indicating that malnutrition was not induced. As a measurement
of discomfort, the VAS nausea scores were significantly increased in patients following the restricted
diet, but since the scores did not exceed 2.5 points out of 10, nausea cannot be considered highly
clinically relevant. The patients that withdrew early from the diet reported discomfort, mostly
gastrointestinal tract-related, as the reason for withdrawal. This discomfort could be due to the liquid
composition of the diet, since the change from normal food to liquid meal replacements has a direct
effect on defecation. Offering patients more solid nutrition could reduce this discomfort and increase
compliance. Interestingly, the morbidly obese patients more often complained about gastrointestinal
symptoms during the restricted diet than the kidney donors did. A possible explanation is provided
by the link between obesity and functional gastrointestinal disorders (FGIDS), such as irritable bowel
syndrome and diarrhea [27]. FGIDS could make obese people more vulnerable to gastrointestinal
symptoms when nutritional intake changes. During the DER-diet, both serum albumin and free
saturated fatty acids increased. Together with the complaints related to gastrointestinal tract and
nutritional intake, these results indicate that the patients on the DER-diet received relatively more fat
than during normal food consumption. This could be the cause of nausea and stool change reported
by the DER-diet groups. Based on the incidence and severity of the discomfort, together with the
percentage of withdrawals from the DER-diet group and metabolic changes, we do not consider the
DER-diet an appropriate control diet for future studies.
Ideally, determination of adherence to the diet would be based on objective measures. It has
been shown that higher intake of calories and protein significantly increases PAB and RBP in patients
at risk for malnutrition [28–30]. Both PAB and RBP significantly decreased in patients receiving the
restricted diet in this study, while no changes were seen in the DER-diet group, in the control group, or
in individuals who did not complete the diet. With only small interpatient variability, both markers
therefore have great value in terms of objectively measuring compliance to a restricted diet. In addition,
serum levels of BCAAs valine and leucine as well as the combination of all three BCAAs decreased
in the restricted diet, with no changes in the DER-diet and the control group. This decrease with
lowered protein intake is in line with a recent study by Solon-Biet et al. who showed that higher levels
of circulating BCAAs were correlated with the percentage of protein intake [17]. Patients who received
the restricted diet also showed a significant decrease in serum urea. Previous studies have shown a
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relationship between dietary protein intake and serum urea [31]. Interestingly, one patient provided
the restricted diet showed no decrease in four of these five markers, raising doubts regarding diet
compliance by this individual. Hence, a combination of these markers may very well distinguish
between compliance and non-compliance to a diet comprising DR and PR. Further research is needed
to validate these markers in larger cohorts of different patient populations in order to establish their
independent value as compliance markers.
This pilot study has some limitations, including a high percentage of dropouts, a small sample
size, and the exclusion of some blood samples that were obtained from non-fasted patients. The high
number of dropouts was mostly due to logistical reasons; in some cases, the surgery date was moved
up, and in others the patients did not undergo surgery. Some of the included patients declined to
participate after providing written informed consent due to the stressful period prior to surgery; these
patients were subsequently excluded. These logistical problems are difficult to solve, and further
studies should anticipate a relatively high percentage of dropouts. Ensuring that the patients fast
overnight before blood is drawn will increase the sample size and the potential value of the study.
Finally, a larger sample size is needed in order to validate the results of this study and to investigate
the effects of a diet comprising DR and PR on perioperative and postoperative responses.
Although safety was not an outcome measure, we have carefully monitored the patients’ peri-,
and postoperative course in the present study, and have observed no differences in type and rate of
complications and length of hospital stay between the three study groups.
In conclusion, our results show that a diet comprising DR and PR is feasible in both kidney
donors and in morbidly obese patients awaiting surgery. This restricted diet was easily instituted, and
adherence to the diet could be measured objectively using a combination of laboratory parameters.
Minor adaptations to the diet, such as increasing the amount of non-liquid food during the diet,
could lead to an even higher compliance rate and to decreased discomfort. This short-term dietary
intervention is feasible and ready for further investigation of the effects of dietary restriction on
perioperative and postoperative responses in a clinical setting.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/8/5/306/s1,
Figure S1: Flowchart showing patient inclusions and exclusions, Figure S2: Timeline of the study from the first
outpatient clinic visit until the end of the trial, Figure S3: Flowchart of the randomization and follow-up of the
inclusions, Table S1: The composition and energy content of the restricted diet and DER-diet, Table S2: List of
all parameters measured and the material and method of analysis, CONSORT 2010 checklist of information to
include when reporting a randomised trial.
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